A Randomized, Crossover Study Evaluating the Acceptability of Unflavored Asenapine and Raspberry Flavored Asenapine in Stable Subjects With A Psychotic Disorder.

At a glance
Trial Overview
Trial Details
Interventions
Trial Centres
- Centres
Trial History
References

Trial Profile

A Randomized, Crossover Study Evaluating the Acceptability of Unflavored Asenapine and Raspberry Flavored Asenapine in Stable Subjects With A Psychotic Disorder.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 08 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Asenapine (Primary)
Indications Bipolar disorders; Depressive disorders; Psychotic disorders; Schizoaffective disorder; Schizophrenia
Focus Therapeutic Use
Sponsors Merck Sharp & Dohme Corp.; Organon; Schering-Plough

Most Recent Events

06 Oct 2009 Schering-Plough added instead of Organon as Organon was taken over by Schering-Plough.
17 Apr 2009 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com